Flagship explainer

How NEOGENOMICS, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$727M · 100%Cost of revenue$413M · 57%Gross profit$314M · 43%Operating income−$116M · −16%Income before tax−$110M · −15%Income tax−$2.2M · −0%Net income−$108M · −15%As of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$727M100%
Cost of revenue$413M57%
$314M43%
−$116M−16%
Income before tax−$110M−15%
Income tax−$2.2M−0%
−$108M−15%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full NEOGENOMICS, INC. analysis at Buy Like Buffett